Verano Receives Permission to File U.S. GAAP Financials on SEDAR and Withdraws MCTO Application
CHICAGO – Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF), a multi-state cannabis company, announced it has received a decision from the Alberta Securities Commission and Ontario Securities Commission permitting the Company to file on the System for Electronic Document Analysis and Retrieval (“SEDAR”) in Canada at www.sedar.com its 2021 annual and 2022 first quarter financial statements and related management’s discussion and analysis prepared in accordance with U.S. GAAP and with respect to the annual financials, audited in accordance with United States auditing standards. As a result of the Decision, the Company has withdrawn its application for a management cease trade order previously disclosed in the Company’s April 26, 2022 press release.
While awaiting the issuance of the Decision, out of an abundance of caution, the Company submitted an application ahead of the May 2, 2022 deadline for the filing of IFRS 2021 audited financial statements (the “IFRS 2021 Annual Financials”) under National Policy 12-203 – Management Cease Trade Orders requesting that a MCTO be granted as a result of of the potential late filing of the IFRS 2021 Annual Financials.
On April 29, 2022, the ASC and OSC issued the Decision to grant the Company its requested exemptive relief. Accordingly, the Company is filing its U.S. GAAP prepared audited annual financial statements on SEDAR in Canada at www.sedar.com to satisfy its May 2, 2022 filing obligations, and the original MCTO application has been withdrawn.
(This information is primarily sourced from Verano Holdings Corp. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...